News >

Focus in Oncogene-Driven NSCLC Turns to Sequencing Strategies, Overcoming Resistance

Caroline Seymour
Published: Thursday, Apr 25, 2019

Kartik Konduri, MD
Kartik Konduri, MD
The ability to target driver mutations among patients with non–small cell lung cancer (NSCLC) continues to grow with combination therapies and newer agents, and research is now focusing on sequential treatment for other key targets, explained Kartik Konduri, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Community Practice Connections™: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for NursesJun 29, 20191.5
Publication Bottom Border
Border Publication